Platform
Novelna's platform is optimized for the rapid identification and clinical validation of novel protein biomarkers, enabling us to develop a diverse array of medical tests more efficiently.
The scientific question defines the model, the measurement approach, and the evidence required.
Discover. Refine. Validate. Translate.
Discover
Profile biological samples and investigate disease-associated protein patterns. Our laboratory programs include blood- and urine-based discovery.
Refine
Identify focused biomarker panels and models appropriate to the clinical question, while examining technical performance and potential confounding.
Validate
Evaluate measurement performance and model behavior in appropriate independent data and clinical studies. Evidence standards follow the intended use.
Translate
Develop a deployable assay, device, or software workflow with the relevant clinical, manufacturing, usability, and regulatory work.
Earlier. Longitudinal. Individualized.
Earlier detection
Investigate diagnostic signals before disease becomes clinically advanced, with multi-cancer and cancer-specific research programs.
Longitudinal monitoring
Develop tools to follow molecular biology across time, initially focused on inflammation after myocardial infarction.
Precision care
Connect biological measurements to patient-specific forecasts and clinician-reviewed intervention strategies in critical illness.
Applications of our Tests
While our platform primarily focuses on cancer, it takes a universal approach to disease detection, offering early detection solutions for a wide range of other diseases through our adaptable technology.
